CytomX Therapeutics(CH:6C1)
CH:6C1
CytomX Therapeutics Revenue
CytomX Therapeutics (6C1) Revenue
0 Followers
CytomX Therapeutics Revenue
CytomX Therapeutics had a revenue of 1.69M in the quarter ending Sep 30, 2026, with 19.04%. This bring the company's revenue in the last twelve months to 14.03M, Decreased 23.36%. In the fiscal year ending Dec 31, 2025, CytomX Therapeutics had annual revenue of 76.20M with -44.82% growth.
- Revenue (ttm)
- 14.03M
- Revenue Growth
- -88.87%
- P/S Ratio
- 4.71
- Revenue/Employee
- CHF 1,104,362
- Employees
- 69
- Market Cap
- CHF 359.24M
Revenue Chart
CytomX Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 76.20M | -61.90M | -44.82% |
| Dec 31, 2024 | 138.10M | 36.89M | 36.45% |
| Dec 31, 2023 | 101.21M | 48.05M | 90.38% |
| Dec 31, 2022 | 53.16M | 15.85M | 42.48% |
| Dec 31, 2021 | 37.31M | -31.11M | -45.47% |
| Dec 31, 2020 | 68.43M | 10.94M | 19.03% |
| Dec 31, 2019 | 57.49M | -2.01M | -3.38% |
| Dec 31, 2018 | 59.50M | -12.12M | -16.92% |
| Dec 31, 2017 | 71.62M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.